BRAF mutation positive papillary thyroid carcinoma is less advanced when Hashimoto's thyroiditis lymphocytic infiltration is present.
about
Nodular goiter with amyloid deposition in an elderly patient: fine-needle cytology diagnosis and review of the literatureEarly cytological diagnosis of extranodal stage I, primary thyroid Non-Hodgkin lymphoma in elderly patients. Report of two cases and review of the literature.Association between BRAF V600E Mutation and Ultrasound Features in Papillary Thyroid Carcinoma Patients with and without Hashimoto's ThyroiditisGenetic mutations in the treatment of anaplastic thyroid cancer: a systematic review.Diagnostic utility of BRAFV600E mutation testing in thyroid nodules in elderly patients.The Warthin-Like Variant of Papillary Thyroid Carcinoma: A Comparison with Classic Type in the Patients with Coexisting Hashimoto's Thyroiditis.Risk of lymph node metastases in multifocal papillary thyroid cancer associated with Hashimoto's thyroiditis.The next generation of orthotopic thyroid cancer models: immunocompetent orthotopic mouse models of BRAF V600E-positive papillary and anaplastic thyroid carcinomaBRAF(V600E) assessment by pyrosequencing in fine needle aspirates of thyroid nodules with concurrent Hashimoto's thyroiditis is a reliable assay.Radioiodide induces apoptosis in human thyroid tissue in culture.One-third of an Archivial Series of Papillary Thyroid Cancer (Years 2007-2015) Has Coexistent Chronic Lymphocytic Thyroiditis, Which Is Associated with a More Favorable Tumor-Node-Metastasis Staging.Clinical implications of the BRAF mutation in papillary thyroid carcinoma and chronic lymphocytic thyroiditis.Co-existence of BRAFV600E and TERT promoter mutations in papillary thyroid carcinoma is associated with tumor aggressiveness, but not with lymph node metastasis.
P2860
Q27025120-298D4DB3-5F47-4DEF-9B89-CD302F4B248AQ27690371-8248AD8F-081B-4906-AC9E-B6D2FCE2E409Q33884794-5CA01C2F-F4E5-495C-B6CF-13FBFE3E2A95Q35051065-64E64152-8C15-4023-820D-764B8FE24C19Q35051461-99B2963A-7B51-46E2-8184-2B49CCA3F31CQ35578725-06F86A20-A1DD-4ECF-BA72-9CF72D508348Q37564120-A89A3A87-00D0-4D87-B3B3-4DCA8C9E3BF0Q37712700-C689D813-E6FF-478B-943D-C5190E70C7B9Q43429193-BE41BE42-10F8-49D4-B06A-DD3292B5B636Q45944006-2EBB2B7A-8508-437B-A105-D8A95546CD3EQ47302732-38E0012D-A4B4-4076-977B-4E7A02CF4FEAQ48277436-58E403E3-57CB-4AE0-829F-C891094318BCQ55436824-2ACFD0EE-A589-4C5F-9922-F3C15F541C2C
P2860
BRAF mutation positive papillary thyroid carcinoma is less advanced when Hashimoto's thyroiditis lymphocytic infiltration is present.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
BRAF mutation positive papilla ...... cytic infiltration is present.
@en
BRAF mutation positive papilla ...... cytic infiltration is present.
@nl
type
label
BRAF mutation positive papilla ...... cytic infiltration is present.
@en
BRAF mutation positive papilla ...... cytic infiltration is present.
@nl
prefLabel
BRAF mutation positive papilla ...... cytic infiltration is present.
@en
BRAF mutation positive papilla ...... cytic infiltration is present.
@nl
P2093
P2860
P50
P356
P1476
BRAF mutation positive papilla ...... cytic infiltration is present.
@en
P2093
Anna Guerra
Ettore Degli Uberti
Mario Vitale
Vincenza Di Stasi
Vincenzo Marotta
P2860
P304
P356
10.1111/CEN.12194
P577
2013-04-01T00:00:00Z